Atlanta Braves Holdings, Inc. (BATRA)
(Real Time Quote from BATS)
$41.08 USD
+0.40 (0.98%)
Updated May 15, 2024 10:07 AM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for Atlanta Braves Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 641 | 589 | NA | NA | NA |
Cost Of Goods | 491 | 437 | NA | NA | NA |
Gross Profit | 149 | 152 | NA | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 196 | 183 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -46 | -31 | 0 | 0 | 0 |
Non-Operating Income | -45 | 29 | NA | NA | NA |
Interest Expense | 38 | 30 | NA | NA | NA |
Pretax Income | -129 | -32 | NA | NA | NA |
Income Taxes | -4 | 3 | NA | NA | NA |
Minority Interest | 0 | 0 | NA | NA | NA |
Investment Gains/Losses | 0 | 0 | NA | NA | NA |
Other Income/Charges | 0 | 0 | NA | NA | NA |
Income From Cont. Operations | -125 | -34 | NA | NA | NA |
Extras & Discontinued Operations | 0 | 0 | NA | NA | NA |
Net Income (GAAP) | -125 | -34 | NA | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 25 | 41 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 71 | 72 | NA | NA | NA |
Income After Depreciation & Amortization | -46 | -31 | 0 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 61.72 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -2.03 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -2.03 | NA | NA | NA | NA |
Fiscal Year end for Atlanta Braves Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 37.08 | 67.75 | 271.82 | 270.12 | 30.97 |
Cost Of Goods | 47.46 | 54.35 | 200.44 | 197.73 | 38.70 |
Gross Profit | -10.38 | 13.40 | 71.38 | 72.39 | -7.73 |
SG&A, R&D, and Dept/Amort Expenses | 41.97 | 45.77 | 55.67 | 52.93 | 41.53 |
Income After SG&A, R&D, and Dept/Amort Expenses | -52.35 | -32.37 | 15.71 | 19.46 | -49.26 |
Non-Operating Income | 6.37 | 3.70 | -3.85 | -30.79 | -14.10 |
Interest Expense | 9.44 | 9.66 | 9.66 | 9.45 | 8.91 |
Pretax Income | -55.43 | -38.33 | 2.21 | -20.77 | -72.27 |
Income Taxes | -4.16 | -5.97 | 8.26 | 8.14 | -14.29 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -51.27 | -32.36 | -6.05 | -28.91 | -57.98 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -51.27 | -32.36 | -6.05 | -28.91 | -57.98 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 61.77 | 62.23 | 61.72 | 54.00 | NA |
Diluted EPS Before Non-Recurring Items | -0.83 | -0.52 | -0.10 | -0.55 | NA |
Diluted Net EPS (GAAP) | -0.83 | -0.52 | -0.10 | 0.33 | NA |